3IP
3Chopt Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.91M | Buy |
62,786
+5,760
| +10% | +$267K | 0.7% | 34 |
|
2025
Q1 | $3.48M | Buy |
57,026
+4,021
| +8% | +$245K | 0.91% | 25 |
|
2024
Q4 | $3M | Buy |
53,005
+2,726
| +5% | +$154K | 1.03% | 31 |
|
2024
Q3 | $2.6M | Buy |
50,279
+4,940
| +11% | +$256K | 0.93% | 38 |
|
2024
Q2 | $1.88M | Buy |
45,339
+7,465
| +20% | +$310K | 0.57% | 42 |
|
2024
Q1 | $2.05M | Buy |
37,874
+10,923
| +41% | +$592K | 0.84% | 39 |
|
2023
Q4 | $1.38M | Buy |
26,951
+4,640
| +21% | +$238K | 0.51% | 55 |
|
2023
Q3 | $1.29M | Buy |
22,311
+6,894
| +45% | +$400K | 0.76% | 42 |
|
2023
Q2 | $986K | Buy |
15,417
+3,584
| +30% | +$229K | 0.49% | 58 |
|
2023
Q1 | $820K | Buy |
11,833
+6,545
| +124% | +$454K | 0.44% | 66 |
|
2022
Q4 | $380K | Buy |
+5,288
| New | +$380K | 0.21% | 94 |
|